JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

Search

Palvella Therapeutics Inc

Open

SectorHealthcare

127.18 4.04

Overview

Share price change

24h

Current

Min

120.11

Max

127.33

Key metrics

By Trading Economics

Income

-1.4M

-13M

Employees

29

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+84.58% upside

Dividends

By Dow Jones

Next Earnings

14 May 2026

Market Stats

By TradingEconomics

Market Cap

249M

1.6B

Previous open

123.14

Previous close

127.18

News Sentiment

By Acuity

12%

88%

19 / 348 Healthcare

Palvella Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

29 Apr 2026, 23:53 UTC

Earnings

Naver Posts Weaker First-Quarter Earnings

29 Apr 2026, 23:41 UTC

Hot Stocks

Stocks to Watch: Meta Platforms, Alphabet, Qualcomm, Amazon.com

29 Apr 2026, 23:55 UTC

Earnings

Samsung Electronics 1Q Net Profit Beat FactSet-Compiled Consensus

29 Apr 2026, 23:54 UTC

Earnings

Samsung Electronics 1Q Net KRW47.225T Vs. Net KRW8.223T >005930.SE

29 Apr 2026, 23:52 UTC

Earnings

Samsung Electronics 1Q Oper Pft KRW57.233T Vs. Pft KRW6.685T >005930.SE

29 Apr 2026, 23:51 UTC

Earnings

Samsung Electronics 1Q Rev KRW133.873T Vs. KRW79.141T >005930.SE

29 Apr 2026, 23:51 UTC

Market Talk

Nikkei May Fall Amid Uncertainty Over Mideast Conflict -- Market Talk

29 Apr 2026, 23:34 UTC

Market Talk

Gold Edges Higher on Likely Technical Recovery -- Market Talk

29 Apr 2026, 23:24 UTC

Earnings

CSC Financial 1Q Results Supported By Higher Income From Fees, Commission>6066.HK

29 Apr 2026, 23:24 UTC

Earnings

CSC Financial Gains From Changes in Fair Value on Financial Assets Also Aided Results>6066.HK

29 Apr 2026, 23:24 UTC

Earnings

CSC Financial 1Q Net CNY3.67B Vs. Net CNY1.84B >6066.HK

29 Apr 2026, 23:24 UTC

Earnings

CSC Financial 1Q Rev CNY7.70B Vs. CNY4.74B >6066.HK

29 Apr 2026, 23:22 UTC

Earnings

China Longyuan 1Q Net CNY1.70B, Down 14%

29 Apr 2026, 23:22 UTC

Earnings

China Longyuan: Power Generation Down 2.9% as of End-March

29 Apr 2026, 23:20 UTC

Earnings

China Longyuan: 1Q Rev From Wind Power Fell, Rev From Solar Power Rose

29 Apr 2026, 23:20 UTC

Earnings

China Longyuan 1Q Rev CNY7.87B, Down 3.6%

29 Apr 2026, 23:19 UTC

Earnings

China Vanke 1Q Loss CNY5.95B Vs. Loss CNY6.25B >000002.SZ

29 Apr 2026, 23:19 UTC

Earnings

China Vanke: Weak China Real Estate Market Continue to Weigh on Results>000002.SZ

29 Apr 2026, 23:19 UTC

Earnings

China Vanke 1Q Rev CNY28.93B Vs. CNY37.99B >000002.SZ

29 Apr 2026, 23:19 UTC

Earnings

China Vanke 1Q Loss Narrows>000002.SZ

29 Apr 2026, 23:18 UTC

Earnings

Naver1Q Net Profit Missed FactSet-Compiled Consensus

29 Apr 2026, 23:17 UTC

Earnings

Naver 1Q Net KRW291.00B Vs. Net KRW423.70B >035420.SE

29 Apr 2026, 23:15 UTC

Earnings

Naver 1Q Oper Pft KRW541.80B Vs. Pft KRW505.30B >035420.SE

29 Apr 2026, 23:15 UTC

Earnings

Naver 1Q Rev KRW3.241T Vs. KRW2.787T >035420.SE

29 Apr 2026, 23:13 UTC

Earnings

CICC: Gains From Investments in Financial Instruments Also Aided Results >3908.HK

29 Apr 2026, 23:12 UTC

Earnings

CICC Results Supported by Increase in Fee, Commission Income >3908.HK

29 Apr 2026, 23:11 UTC

Earnings

CICC 1Q Rev CNY8.83B Vs. CNY5.72B >3908.HK

29 Apr 2026, 23:11 UTC

Earnings

CICC 1Q Net CNY3.58B Vs. Net CNY2.04B >3908.HK

29 Apr 2026, 23:04 UTC

Earnings

Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist -- WSJ

29 Apr 2026, 23:04 UTC

Earnings

Meta Reports Big Revenue Jump and Projected Spending Increase -- 3rd Update

Peer Comparison

Price change

Palvella Therapeutics Inc Forecast

Price Target

By TipRanks

84.58% upside

12 Months Forecast

Average 232.5 USD  84.58%

High 270 USD

Low 209 USD

Based on 13 Wall Street analysts offering 12 month price targets forPalvella Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

13

Buy

0

Hold

0

Sell

Sentiment

By Acuity

19 / 348 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Interest expense on debt

Operating profit

$

help-icon Live chat